Nevertheless, HSCT in XIAP patients has been associated initially with bad prognosis compared with slam-associated protein deficiency and there are a limited number of studies concerning the outcomes of HSCT in patients with XIAP deficiency (32–39). The gene discussed is XIAP; the disease is hereditary thrombophilia due to congenital protein S deficiency.